These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 37392012)

  • 21. Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials.
    Noorani T; Bedi G; Muthukumaraswamy S
    Psychol Med; 2023 Oct; 53(13):5892-5901. PubMed ID: 37466178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.
    Borkel LF; Rojas-Hernández J; Henríquez-Hernández LA; Santana Del Pino Á; Quintana-Hernández DJ
    Expert Rev Clin Pharmacol; 2024; 17(2):165-176. PubMed ID: 38108102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychedelics and Psychotherapy.
    Nayak S; Johnson MW
    Pharmacopsychiatry; 2021 Jul; 54(4):167-175. PubMed ID: 33285578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D; Barrett FS; Vandrey R
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a New Science of Psychedelic Social Psychology: The Effects of MDMA (Ecstasy) on Social Connection.
    Lyubomirsky S
    Perspect Psychol Sci; 2022 Sep; 17(5):1234-1257. PubMed ID: 35536567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.
    Hovmand OR; Poulsen ED; Arnfred S; Storebø OJ
    J Psychopharmacol; 2023 Jul; 37(7):649-659. PubMed ID: 37403379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with psychedelic drugs in human volunteers.
    Sellers EM; Romach MK; Leiderman DB
    Neuropharmacology; 2018 Nov; 142():116-134. PubMed ID: 29162429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.
    Garcia-Romeu A; Richards WA
    Int Rev Psychiatry; 2018 Aug; 30(4):291-316. PubMed ID: 30422079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic mechanisms of psychedelics and entactogens.
    Heifets BD; Olson DE
    Neuropsychopharmacology; 2024 Jan; 49(1):104-118. PubMed ID: 37488282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.
    Palitsky R; Kaplan DM; Peacock C; Zarrabi AJ; Maples-Keller JL; Grant GH; Dunlop BW; Raison CL
    JAMA Psychiatry; 2023 Jul; 80(7):743-749. PubMed ID: 37256584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychedelic Drugs in Biomedicine.
    Kyzar EJ; Nichols CD; Gainetdinov RR; Nichols DE; Kalueff AV
    Trends Pharmacol Sci; 2017 Nov; 38(11):992-1005. PubMed ID: 28947075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
    Moreton SG; Szalla L; Menzies RE; Arena AF
    Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Making Sense of Psychedelics in the CNS.
    Fordyce BA; Roth BL
    Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38289825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Past and Future of Psychedelic Science: An Introduction to This Issue.
    Doblin RE; Christiansen M; Jerome L; Burge B
    J Psychoactive Drugs; 2019; 51(2):93-97. PubMed ID: 31132970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health.
    Barnett BS
    J Psychopharmacol; 2022 Oct; 36(10):1097-1099. PubMed ID: 36112818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.
    Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ
    Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
    Palhano-Fontes F; Barreto D; Onias H; Andrade KC; Novaes MM; Pessoa JA; Mota-Rolim SA; Osório FL; Sanches R; Dos Santos RG; Tófoli LF; de Oliveira Silveira G; Yonamine M; Riba J; Santos FR; Silva-Junior AA; Alchieri JC; Galvão-Coelho NL; Lobão-Soares B; Hallak JEC; Arcoverde E; Maia-de-Oliveira JP; Araújo DB
    Psychol Med; 2019 Mar; 49(4):655-663. PubMed ID: 29903051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.